EIF5
Basic information
Region (hg38): 14:103333544-103345025
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EIF5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 0 | 0 |
Variants in EIF5
This is a list of pathogenic ClinVar variants found in the EIF5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-103335901-A-G | not specified | Uncertain significance (Jun 29, 2022) | ||
14-103336821-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
14-103337157-A-C | not specified | Uncertain significance (Mar 07, 2023) | ||
14-103337212-C-T | not specified | Uncertain significance (Aug 06, 2021) | ||
14-103338342-G-A | not specified | Uncertain significance (Feb 13, 2025) | ||
14-103338351-A-G | not specified | Uncertain significance (Apr 26, 2023) | ||
14-103338408-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
14-103338419-A-G | not specified | Uncertain significance (Sep 24, 2024) | ||
14-103338447-A-G | not specified | Uncertain significance (Dec 22, 2023) | ||
14-103338455-C-A | not specified | Uncertain significance (Mar 01, 2024) | ||
14-103338458-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
14-103338747-G-A | not specified | Uncertain significance (Sep 26, 2024) | ||
14-103338749-T-G | not specified | Uncertain significance (Aug 01, 2024) | ||
14-103338756-T-A | not specified | Uncertain significance (Feb 12, 2024) | ||
14-103338789-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
14-103338793-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
14-103339164-C-T | Benign (Jan 19, 2018) | |||
14-103339203-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
14-103339259-C-A | not specified | Uncertain significance (Sep 05, 2024) | ||
14-103339277-C-A | not specified | Uncertain significance (Jun 22, 2021) | ||
14-103339298-G-C | not specified | Uncertain significance (Feb 21, 2025) | ||
14-103339647-C-A | not specified | Uncertain significance (Dec 29, 2024) | ||
14-103339656-A-C | not specified | Uncertain significance (Jan 01, 2025) | ||
14-103339702-A-G | not specified | Uncertain significance (Oct 01, 2024) | ||
14-103339796-C-G | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EIF5 | protein_coding | protein_coding | ENST00000216554 | 10 | 11482 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.988 | 0.0124 | 125736 | 0 | 8 | 125744 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.56 | 178 | 247 | 0.721 | 0.0000134 | 2893 |
Missense in Polyphen | 22 | 62.368 | 0.35274 | 780 | ||
Synonymous | -3.14 | 118 | 81.8 | 1.44 | 0.00000450 | 757 |
Loss of Function | 3.96 | 2 | 22.1 | 0.0906 | 0.00000116 | 280 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000126 | 0.000125 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000361 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of GTP bound to the 40S ribosomal initiation complex (40S.mRNA.Met-tRNA[F].eIF-2.GTP) with the subsequent joining of a 60S ribosomal subunit resulting in the release of eIF-2 and the guanine nucleotide. The subsequent joining of a 60S ribosomal subunit results in the formation of a functional 80S initiation complex (80S.mRNA.Met-tRNA[F]).;
- Pathway
- RNA transport - Homo sapiens (human);Translation Factors;Eukaryotic Translation Initiation;Translation;Metabolism of proteins;regulation of eif2;eukaryotic protein translation;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.112
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.793
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.661
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.961
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eif5
- Phenotype
Gene ontology
- Biological process
- formation of translation preinitiation complex;translational initiation;regulation of translational initiation;activation of GTPase activity
- Cellular component
- nucleus;cytoplasm;cytosol;plasma membrane
- Molecular function
- RNA binding;translation initiation factor activity;GTPase activity;protein binding;GTP binding;translation factor activity, RNA binding;cadherin binding;eukaryotic initiation factor eIF2 binding